ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $360,159 | +1643.1% | 282,478 | +624.6% | 0.00% | – |
Q4 2022 | $20,662 | -55.1% | 38,984 | -38.3% | 0.00% | – |
Q3 2022 | $46,000 | -64.6% | 63,215 | -0.2% | 0.00% | – |
Q1 2022 | $130,000 | -54.7% | 63,346 | -36.5% | 0.00% | – |
Q4 2021 | $287,000 | -60.2% | 99,705 | -41.4% | 0.00% | – |
Q3 2021 | $721,000 | +41.1% | 170,184 | +76.5% | 0.00% | – |
Q2 2021 | $511,000 | -36.9% | 96,399 | -44.6% | 0.00% | – |
Q1 2021 | $810,000 | +73.8% | 174,131 | +26.0% | 0.00% | – |
Q2 2020 | $466,000 | +441.9% | 138,145 | +1116.9% | 0.00% | – |
Q3 2019 | $86,000 | -64.8% | 11,352 | -37.0% | 0.00% | – |
Q2 2019 | $244,000 | +577.8% | 18,005 | +46.8% | 0.00% | – |
Q4 2018 | $36,000 | -87.6% | 12,267 | -65.5% | 0.00% | -100.0% |
Q3 2018 | $290,000 | +21.3% | 35,555 | +44.6% | 0.00% | 0.0% |
Q2 2018 | $239,000 | – | 24,588 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cruiser Capital Advisors, LLC | 36,888 | $301,000 | 0.15% |
Kazazian Asset Management, LLC | 18,792 | $153,000 | 0.14% |
Fiduciary Trust Co International of Pennsylvania | 202,100 | $1,649,000 | 0.07% |
Engineers Gate Manager LP | 66,270 | $541,000 | 0.04% |
THOMPSON DAVIS & CO., INC. | 1,534 | $13,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 23,700 | $193,000 | 0.02% |
A.R.T. Advisors, LLC | 43,360 | $353,000 | 0.02% |
Cutler Group LLC / CA | 20,822 | $186,000 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 63,614 | $519,000,000 | 0.01% |
FNY Investment Advisers, LLC | 6,000 | $48,000 | 0.01% |